Salmon calcitonin in the treatment of postmenopausal osteoporosis

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.

Original languageEnglish (US)
Pages (from-to)923-925
Number of pages3
JournalAnnals of internal medicine
Volume107
Issue number6
DOIs
StatePublished - Jan 1 1987

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine

Cite this